Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation

References

• Irvine KD, Harvey KF. Control of organ growth by patterning and hippo signaling in Drosophila. Cold Spring Harb Perspect Biol 2015; 7(6):pii: a019224; PMID:26032720; http://dx.doi.org/10.1101/cshperspect.a019224
   PubMed Web of Science ®Google Scholar
• Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19(4):491-505; PMID:20951342; http://dx.doi.org/10.1016/j.devcel.2010.09.011
   PubMed Web of Science ®Google Scholar
• Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol 2013; 25(2):247-53; PMID:23312716; http://dx.doi.org/10.1016/j.ceb.2012.12.006
   PubMed Web of Science ®Google Scholar
• Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13(8):877-83; PMID:21808241; http://dx.doi.org/10.1038/ncb2303
   PubMed Web of Science ®Google Scholar
• Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130(6):1120-33; PMID:17889654; http://dx.doi.org/10.1016/j.cell.2007.07.019
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005; 122(3):421-34; PMID:16096061; http://dx.doi.org/10.1016/j.cell.2005.06.007
   PubMed Web of Science ®Google Scholar
• Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 2015; 163(4):811-28; PMID:26544935; http://dx.doi.org/10.1016/j.cell.2015.10.044
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13(4):246-57; PMID:23467301; http://dx.doi.org/10.1038/nrc3458
   PubMed Web of Science ®Google Scholar
• Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 2006; 103(33):12405-10; PMID:16894141; http://dx.doi.org/10.1073/pnas.0605579103
   PubMed Web of Science ®Google Scholar
• Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009; 11(12):1444-50; PMID:19935651; http://dx.doi.org/10.1038/ncb1993
   PubMed Web of Science ®Google Scholar
• Sudol M, Chen HI, Bougeret C, Einbond A, Bork P. Characterization of a novel protein-binding module–the WW domain. FEBS Lett 1995; 369(1):67-71; PMID:7641887; http://dx.doi.org/10.1016/0014-5793(95)00550-S
   PubMed Web of Science ®Google Scholar
• Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 1994; 9(8):2145-52; PMID:8035999
   PubMed Web of Science ®Google Scholar
• Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 2004; 23(4):790-9; PMID:14765127; http://dx.doi.org/10.1038/sj.emboj.7600073
   PubMed Web of Science ®Google Scholar
• Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 2008; 29(3):350-61; PMID:18280240; http://dx.doi.org/10.1016/j.molcel.2007.12.022
   PubMed Web of Science ®Google Scholar
• Tamm C, Bower N, Anneren C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J Cell Sci 2011; 124(Pt 7):1136-44; PMID:21385842; http://dx.doi.org/10.1242/jcs.075796
   PubMed Web of Science ®Google Scholar
• Vlahov N, Scrace S, Soto MS, Grawenda AM, Bradley L, Pankova D, Papaspyropoulos A, Yee KS, Buffa F, Goding CR, et al. Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion. Curr Biol 2015; 25(23):3019-34; PMID:26549256; http://dx.doi.org/10.1016/j.cub.2015.09.072
   PubMed Web of Science ®Google Scholar
• Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, et al. beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis. Cell 2012; 151(7):1457-73; PMID: 23245941; http://dx.doi.org/10.1016/j.cell.2012.11.026
   PubMed Web of Science ®Google Scholar
• Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30(3):256-68; PMID:12798140; http://dx.doi.org/10.1016/S1046-2023(03)00032-X
   PubMed Web of Science ®Google Scholar
• Li YW, Shen H, Frangou C, Yang N, Guo J, Xu B, Bshara W, Shepherd L, Zhu Q, Wang J, et al. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis. Cell cycle 2015; 14(1):146-56; PMID:25602524; http://dx.doi.org/10.4161/15384101.2014.967106
   PubMed Web of Science ®Google Scholar
• Frangou C, Li YW, Shen H, Yang N, Wilson KE, Blijlevens M, Guo J, Nowak NJ, Zhang J. Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets. Oncotarget 2014; 5(23):12166-76; PMID:25361000; http://dx.doi.org/10.18632/oncotarget.2570
   PubMed Web of Science ®Google Scholar
• Zhang J, Smolen GA, Haber DA. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 2008; 68(8):2789-94; PMID:18413746; http://dx.doi.org/10.1158/0008-5472.CAN-07-6205
   PubMed Web of Science ®Google Scholar
• Tu C, Li J, Young R, Page BJ, Engler F, Halfon MS, Canty JM Jr, Qu J. Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome. Anal Chem 2011; 83(12):4802-13; PMID:21491903; http://dx.doi.org/10.1021/ac200376m
   PubMed Web of Science ®Google Scholar
• Cao J, Gonzalez-Covarrubias V, Straubinger RM, Wang H, Duan X, Yu H, Qu J, Blanco JG. A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver. Anal Chem 2010; 82(7):2680-9; PMID:20218584; http://dx.doi.org/10.1021/ac902314m
   PubMed Web of Science ®Google Scholar
• Nouri-Nigjeh E, Sukumaran S, Tu C, Li J, Shen X, Duan X, DuBois DC, Almon RR, Jusko WJ, Qu J. Highly multiplexed and reproducible ion-current-based strategy for large-scale quantitative proteomics and the application to protein expression dynamics induced by methylprednisolone in 60 rats. Anal Chem 2014; 86(16):8149-57; PMID:25072516; http://dx.doi.org/10.1021/ac501380s
   PubMed Web of Science ®Google Scholar
• Hao Y, Chun A, Cheung K, Rashidi B, Yang X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 2008; 283(9):5496-509; PMID:18158288; http://dx.doi.org/10.1074/jbc.M709037200
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Gen Dev 2007; 21(21):2747-61; PMID:17974916; http://dx.doi.org/10.1101/gad.1602907
   PubMed Web of Science ®Google Scholar
• Tomlinson V, Gudmundsdottir K, Luong P, Leung KY, Knebel A, Basu S. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis 2010; 1:e29; PMID:21364637; http://dx.doi.org/10.1038/cddis.2010.7
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang L, Liu M, Chong R, Ding SJ, Chen Y, Dong J. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res 2013; 73(22):6722-33; PMID:24101154; http://dx.doi.org/10.1158/0008-5472.CAN-13-2049
   PubMed Web of Science ®Google Scholar
• Zhao Y, Khanal P, Savage P, She YM, Cyr TD, Yang X. YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer Res 2014; 74(16):4493-503; PMID:24812269; http://dx.doi.org/10.1158/0008-5472.CAN-13-2712
   PubMed Web of Science ®Google Scholar
• Fan R, Kim NG, Gumbiner BM. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc Natl Acad Sci U S A 2013; 110(7):2569-74; PMID:23359693; http://dx.doi.org/10.1073/pnas.1216462110
   PubMed Web of Science ®Google Scholar
• Reddy BV, Irvine KD. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev Cell 2013; 24(5):459-71; PMID:23484853; http://dx.doi.org/10.1016/j.devcel.2013.01.020
   PubMed Web of Science ®Google Scholar
• Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, Inazawa J, Golden A, Carey DJ, Farooq A, et al. Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene 2012; 509(2):215-22; PMID:22939869; http://dx.doi.org/10.1016/j.gene.2012.08.025
   PubMed Web of Science ®Google Scholar
• Sudol M. YAP1 oncogene and its eight isoforms. Oncogene 2013; 32(33):3922; PMID:23160371; http://dx.doi.org/10.1038/onc.2012.520
   PubMed Web of Science ®Google Scholar
• Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005; 5(9):675-88; PMID:16148884; http://dx.doi.org/10.1038/nrc1695
   PubMed Web of Science ®Google Scholar
• Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al. TEAD mediates YAP-dependent gene induction and growth control. Gen Dev 2008; 22(14):1962-71; PMID:18579750; http://dx.doi.org/10.1101/gad.1664408
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011; 286(9):7018-26; PMID:21224387; http://dx.doi.org/10.1074/jbc.C110.212621
   PubMed Web of Science ®Google Scholar
• Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, Gelman IH, Zhang J. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 2013; 32(10):1266-73; PMID:22525271; http://dx.doi.org/10.1038/onc.2012.147
   PubMed Web of Science ®Google Scholar
• Wang W, Huang J, Wang X, Yuan J, Li X, Feng L, Park JI, Chen J. PTPN14 is required for the density-dependent control of YAP1. Gen Dev 2012; 26(17):1959-71; PMID:22948661; http://dx.doi.org/10.1101/gad.192955.112
   PubMed Web of Science ®Google Scholar
• Michaloglou C, Lehmann W, Martin T, Delaunay C, Hueber A, Barys L, Niu H, Billy E, Wartmann M, Ito M, et al. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PloS one 2013; 8(4):e61916; PMID:23613971; http://dx.doi.org/10.1371/journal.pone.0061916
   PubMed Web of Science ®Google Scholar
• Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A, Zhang H, Karlan B, Greene MI, Wang Q. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 2013; 32(17):2220-9; PMID:22689061; http://dx.doi.org/10.1038/onc.2012.231
   PubMed Web of Science ®Google Scholar
• Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 2003; 278(35):33334-41; PMID:12807903; http://dx.doi.org/10.1074/jbc.M305597200
   PubMed Web of Science ®Google Scholar
• Haskins JW, Nguyen DX, Stern DF. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci Signal 2014; 7(355):ra116; PMID:25492965; http://dx.doi.org/10.1126/scisignal.2005770
   PubMed Web of Science ®Google Scholar
• Xue Y, Ren J, Gao X, Jin C, Wen L, Yao X. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol Cell Proteomics 2008; 7(9):1598-608; PMID:18463090; http://dx.doi.org/10.1074/mcp.M700574-MCP200
   PubMed Web of Science ®Google Scholar
• Kodaka M, Hata Y. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ. Cell Mol Life Sci 2015; 72(2):285-306; PMID:25266986; http://dx.doi.org/10.1007/s00018-014-1742-9
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Gen Dev 2010; 24(1):72-85; PMID:20048001; http://dx.doi.org/10.1101/gad.1843810
   PubMed Web of Science ®Google Scholar
• Sudol M, Harvey KF. Modularity in the Hippo signaling pathway. Trends Biochem Sci 2010; 35(11):627-33; PMID:20598891; http://dx.doi.org/10.1016/j.tibs.2010.05.010
   PubMed Web of Science ®Google Scholar
• Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 1995; 92(17):7819-23; PMID:7644498; http://dx.doi.org/10.1073/pnas.92.17.7819
   PubMed Web of Science ®Google Scholar
• Schuchardt BJ, Mikles DC, Hoang LM, Bhat V, McDonald CB, Sudol M, Farooq A. Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity. FEBS J 2014; 281(24):5532-51; PMID:25283809; http://dx.doi.org/10.1111/febs.13095
   PubMed Web of Science ®Google Scholar
• Sudol M. Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway. Gen Cancer 2010; 1(11):1115-8; PMID:21779434; http://dx.doi.org/10.1177/1947601911401911
   PubMedGoogle Scholar
• Sudol M, Hunter T. NeW wrinkles for an old domain. Cell 2000; 103(7):1001-4; PMID:11163176; http://dx.doi.org/10.1016/S0092-8674(00)00203-8
   PubMed Web of Science ®Google Scholar
• Sudol M, Shields DC, Farooq A. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Semin Cell Dev Biol 2012; 23(7):827-33; PMID:22609812; http://dx.doi.org/10.1016/j.semcdb.2012.05.002
   PubMed Web of Science ®Google Scholar